Key result
The CHA2DS2-VASc score serves as a clinical tool for stroke risk stratification to guide oral anticoagulation therapy in the management of atrial fibrillation.
Provides a clinical perspective on the use of the CHA2DS2-VASc score for stroke risk stratification in patients with atrial fibrillation.
It is well recognized that stroke prevention is central to the management of atrial fibrillation (AF) [1,2]. The most effective thromboprophylaxis is oral anticoagulation (OAC) and until recently, ...
No takes yet. Share an insight, caveat, or question.
Gregory Y.H. Lip (2013) studied this question. The CHA2DS2-VASc score serves as a clinical tool for stroke risk stratification to guide oral anticoagulation therapy in the management of atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: